Navigation Links
Alexza Reports 2008 Second Quarter Financial Results and Updates Development of Product Candidates
Date:8/6/2008

32,532 28,480 31,879 26,175

Alexza Pharmaceuticals, Inc.

(a development stage enterprise)

Condensed Consolidated Balance Sheets

(in thousands)

June 30, December 31,

2008 2007

Unaudited (1)

Assets

Cash, cash equivalents and marketable

securities $64,005 $69,391

Investments held by Symphony Allegro, Inc. 31,310 39,449

Other current assets 996 13,432

Total current assets 96,311 122,272

Property and equipment, net 25,302 26,156

Other non-current assets 666 697

Total assets $122,279 $149,125

Liabilities, noncontrolling interest

and stockholders' equity

Current liabilities $16,453 $16,180

Non-current liabilities 30,826 33,002

Noncontrolling interest in Symphony

Allegro, Inc. 14,304 23,952

Stockholders equity 60,696 75,991

Total liabilities, non controlling

interest and stockholders' equity $122,279 $149,125

(1) Derived from audited consolidated financial statements at that date.


'/>"/>
SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... , March 5, 2015  ANI Pharmaceuticals, ... announced that it has acquired the approved abbreviated ... USP 50mg, 100mg and 150mg, previously marketed by ... market for this product was approximately $39 million ... Przybyl , President and CEO of ANI Pharmaceuticals, ...
(Date:3/5/2015)... DUBLIN , Mar. 05, 2015 Research and ... addition of the "Japan Pharma Outlook 2015: Year ... Overseas Strategic Initiatives" report to their offering. ... Japan from April -2014 (Annexure 1) ... the companies - whether generic or innovator. The most ...
(Date:3/5/2015)... -- Hitachi Medical Systems Europe is ... *    at ECR 2015 - the open high-field ... benchmark for patient-centric care. The new features of OASIS ... workflow management and costs. OASIS demonstrates the high levels ... in Neurology, Orthopaedics, Paediatrics, Oncology, Vascular and General Imaging, ...
Breaking Medicine Technology:ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals 2ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals 3Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 2Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 3Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 2Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 3
(Date:3/5/2015)... Venice, FL (PRWEB) March 05, 2015 ... their 15th annual listing of “Pros to Know” in ... announce that two members of MEBC’s leadership team were ... Rhodes were nominated and received this award due to ... use of innovative methods for meeting and resolving client ...
(Date:3/5/2015)... March 05, 2015 Dr. Jonathan Glashow ... http://www.orthopedicsurgeonnyc.com ) has been named by Castle Connolly ... Metro area. Dr. Glashow has been selected by Castle ... to the top specialty care doctors in the tri-state ... Castle Connolly program, which carefully screens and selects doctors ...
(Date:3/5/2015)... March 05, 2015 As a ... (AAPA) review of Clearstream, LLC ’s products, ... Clearstream’s MediDefense line of products—led by their mPulse ... Affinity Partner Program. , The AAPA—which represents a ... all medical and surgical specialties in the U.S.—advocates ...
(Date:3/5/2015)... San Diego, CA (PRWEB) March 05, 2015 ... that it is now running on 100% pollution-free ... provider, Arcadia Power. , As an Arcadia ... Environmental Protection Agency’s (EPA) Green Power Partnership requirements, ... and Starbucks that also purchase clean energy. Earth ...
(Date:3/5/2015)... 05, 2015 The Journal of ... a special issue devoted entirely to ... PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococci) ... reaction triggered by infections such as strep throat, ... inflammation of the child's brain. This inflammation causes ...
Breaking Medicine News(10 mins):Health News:MEBC Leaders Awarded Supply Demand Chain Executive Pros to Know Title For 2015 2Health News:Dr. Jonathan Glashow, NYC Orthopedic Surgeon, Named Top Doctor: New York Metro Area 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 3Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 4Health News:Earth Source Organics to Run on Clean Energy from Arcadia Power 2Health News:Controversial Childhood Illness PANDAS the Focus of a Special Medical Journal Issue 2Health News:Controversial Childhood Illness PANDAS the Focus of a Special Medical Journal Issue 3
... The California Institute for Quantitative Biosciences (QB3) has entered ... in its efforts to convert bioscience innovation into a ... Deloitte, which provides consulting, audit, tax and financial ... to help QB3 develop an "innovation ecosystem," bringing together ...
... has often been associated with serious side-effects. Researchers at ... in mice, found a way of utilising the positive ... skeleton is acted on, current research at the Academy ... journal PNAS (Proceedings of the National Academy of Sciences). ...
... reveal your risk of a future heart attack, and it ... detail thanks to a new technique which could eventually be ... a thesis from the University of Gothenburg, Sweden. Atherosclerosis ... of future heart disease, and it is therefore important to ...
... 11) --A study from Tufts Medical Center researchers published today ... patients who have few other options because their disease has ... Cancer Cell, the study is the first published ... (CML) in a mouse model of the disease and is ...
... Salamon HealthDay Reporter , MONDAY, April 11 ... than their peers who don,t have children, and they ... calories, a new study suggests. Examining data from ... Adults), researchers from the University of Minnesota focused on ...
... MONDAY, April 11 (HealthDay News) -- The tone of ... claims a study that challenges previous research suggesting the ... Texas A&M University assessed 175 voice samples provided by ... and found that there were no changes in eight ...
Cached Medicine News:Health News:QB3, Deloitte collaborate to drive California bioscience innovation 2Health News:New potential atherosclerosis risk marker discovered 2Health News:New drug shows potential for treatment-resistant leukemia 2Health News:Having Kids Might Make Young Women Heavier, Less Fit 2Health News:Having Kids Might Make Young Women Heavier, Less Fit 3
Inquire...
... 6-Place Rotor has a standard 1.5ml rotor and ... adapters. Easy operation (no switches to mess with). ... press the plastic tab to open. Starts and ... and 2000 x g. Only five inches in ...
Inquire...
Inquire...
Medicine Products: